Hide

FocusBar

FeedbackFeedback
Subscribe to Premium Member
0 (1y: -100%)
Market Cap 267.86 M P/E(ttm)
Enterprise Value 223.75 M P/B 7.18
BMTI- NAS (USA)
BioMimetic Therapeutics, Inc.
  • Currently 1/5
Business Predictability Rank: 1-Star (On Watch)
Back Testing Results:
Average gain of all 1-Star stocks: 1.1% per year.
% of Stocks that are in still loss if held for 10yrs: 45%.
Read more:
What is Predictability Rank?
Performances of real portfolio
Top Ranked Predictable Companies
$0.00
Switch to:
Jump to: Guru Trade | Guru Ownership | Insider Trade

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M268Revenue $M2.1Net Margin (%)-1,924.1Z-Score-1.2
Enterprise Value $M224EPS $-1.0Operating Margin %-1,759.4F-Score2
P/E(ttm))0Cash Flow Per Share $-1.0Pre-tax Margin (%)-1,924.1Higher ROA y-yN
Price/Book7.210-y EBITDA Growth Rate %0Quick Ratio9.7Cash flow > EarningsY
Price/Sales05-y EBITDA Growth Rate %-6.5Current Ratio11.6Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %ROA % (ttm)-44.3Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)1ROE % (ttm)-61.4Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M28.2ROI % (ttm)-51.9Gross Margin Increase y-yN

Gurus Latest Trades with BMTI

Please Subscribe to see portfolio changes after the end of the last quarter. Real Time Picks are included for Premium Members only! Plans start from as little as $299/year.

7-Day FREE TRIAL
Select Gurus | Default List of Gurus | All Investors | Mutual Fund Gurus | Hedge Fund Gurus
Number of guru portfolios checked: 51.
TickerGuruDate Action
 Impactdown Price Range
(Average)* 		Current Price Change from Average Comment Current Shares
BMTIGeorge Soros 2007-03-31 Sold Out -0.37%$12.4 - $18.34
($15.1)		 $ 9.53-37%Sold Out0
BMTIGeorge Soros 2006-06-30 Buy 0.41%$6.26 - $8.13
($7.5)		 $ 9.5327%New holding, 411199 sh.411,199
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.
Total Records: 2

BMTI is held by these Gurus:

Select Gurus | Default List of Gurus | All Investors | Mutual Fund Gurus | Hedge Fund Gurus
Premium Most recent portfolio changes are included for Premium Members only!


BMTI: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Pagano Russell P.VP, Reg. & Clinical Affairs 2013-01-22Sell1,381$8.1-100view
Friedlaender Gary EDirector 2012-04-02Buy10,000$2.79-100view
Lynch Samuel EugenePresident and CEO 2012-03-30Buy70,000$2.41-100view
Pagano Russell P.VP, Reg. & Clinical Affairs 2012-03-29Sell3,438$2.36-100view
Douglas Earl MartinGeneral Counsel 2012-03-28Sell53,561$2.35-100view
PAPASAN LARRY WDirector 2012-03-27Buy10,400$2.32-100view
Lynch Samuel EugenePresident and CEO 2012-03-23Buy13,150$2.35-100view
BULLOCK LAWRENCE ECFO 2012-03-20Buy20,000$2.2-100view
Friedlaender Gary EDirector 2012-03-19Buy15,000$2.19-100view
Douglas Earl MartinGeneral Counsel 2011-10-14Sell9,000$3.01-100view

Press Releases about BMTI:

Quarterly/Annual Reports about BMTI:

News about BMTI:

Articles On GuruFocus.com
BioMimetic Therapeutics Up $24.28% on July 10 Jul 10 2012 
Weekly CEO Buys Highlight: VRA, MTDR, BMTI, PZG, CAK Apr 10 2012 
Weekly CFO Buys Highlight: SSP, BMTI, POL, ANAC, CYTX Mar 26 2012 
BioMimetic Therapeutics Inc. Reports Operating Results (10-K) Mar 10 2011 
BioMimetic Therapeutics Inc. Reports Operating Results (10-Q) Nov 03 2010 
BioMimetic Therapeutics Inc. Reports Operating Results (10-Q) Aug 05 2010 
BioMimetic Therapeutics Inc. (BMTI) President and CEO Samuel Eugene Lynch sells 6,000 Shares Dec 30 2009 
BioMimetic Therapeutics Inc. (BMTI) President and CEO Samuel Eugene Lynch sells 6,000 Shares Dec 16 2009 
BioMimetic Therapeutics Inc. (BMTI) President and CEO Samuel Eugene Lynch sells 6,000 Shares Dec 04 2009 
BioMimetic Therapeutics Inc. (BMTI) President and CEO Samuel Eugene Lynch sells 6,000 Shares Nov 18 2009 

Add Notes, Comments or Ask Questions

Comments

No comment yet
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names
Free 7-day Trial
FEEDBACK